Clinical trial · Observational
Updating the EORTC Quality-of-Life Questionnaire for Ovarian Cancer (QLQ-OV38)
The Update of the EORTC QLQ-Ovarial Cancer Module (EORTC-QLQ-OV28) - OV39 Phase III
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260919-000001
Summary
Brief summary (as posted)
The goal of this observational study is to pre-test the EORTC QLQ-OV39 to identify and resolve potential problems in its administration and to identify missing/redundant items. A preliminary evaluation of the measurement properties of the module will be carried out. The study includes patients with evidence of localized (FIGO I-II) or advanced ovarian cancer (FIGO II-IV) above the age of 18 years. The main aims are: 1. To conduct Phase 3a and 3b pre-testing of the preliminary EORTC-QLQ-OV39 Questionnaire to identify and resolve potential problems in its administration and to identify missing/redundant items according to the updated EORTC QLG Guidelines for Module Development, 5th Edition 2021.(16) 2. a preliminary assessment of the psychometric properties of the module Participants will \[describe the main tasks participants will be asked to, complete the OV39, C30 and debriefing interviews, as well as questions about their demographics and clinical data.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
| Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Questionnaire
- timeFrame
- Last week or last four weeks
- description
- Questionnaire for the quality of life of ovarian cancer patients. Patients are advised to indicate on a 4-point-Likert scale (1 = not at all; 2 = a little; 3 = quite a bit; 4 = very much) how much a specific issue has occured within a specific time frame and how much this had had an impact on them. Higher scored meaning more impact on quality of life.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Evidence of localized (FIGO I-II) or advanced ovarian cancer (FIGO II-IV) 2. Must be able and willing to complete the questionnaires. 3. Must be able to understand and speak the language in which the patient will complete the questionnaire. 4. Age \> 18 years Exclusion Criteria: * cognitive impairment
References
Publications (0)
Data not yet available